Novartis Ag (NVS) Assets Average (2009 - 2010)
Novartis Ag (NVS) posted Assets Average of $47897547.8 billion for Q1 2010, up 100303553.78% sequentially from $47.8 billion in Q4 2009, and up 122861356041694.06% YoY from N/an in Q1 2009.
Novartis Ag (NVS) Assets Average (2009 - 2010) Analysis & Trends
Novartis Ag has reported Assets Average for 2 years, with the latest figure at $47897547.8 billion in Q1 2010.
- Quarterly Assets Average rose 122861356041694.06% year-over-year to $47897547.8 billion in Q1 2010, while the trailing twelve-month figure through Mar 2010 was $47897547.8 billion (up 122861356041694.06% YoY) and the FY2025 annual result came in at $106.6 billion, up 5.44% from the prior year.
- Assets Average climbed to $47897547.8 billion in Q1 2010 per NVS's latest filing, from $47.8 billion in the prior quarter.
- Over five years, Assets Average peaked at $47897547.8 billion in Q1 2010 and troughed at $38985.0 in Q1 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 114.92 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 94.07 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 52.82 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 204.57 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 83.80 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 149.95 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | 47,897,547.75 Bn |
| Dec 31, 2009 | 47.75 Bn |
| Sep 30, 2009 | 87,480.00 |
| Jun 30, 2009 | 81,122.00 |
| Mar 31, 2009 | 38,985.04 |